Navigation Links
Barr Confirms Patent Challenge of UROXATRAL(R)
Date:9/25/2007

rmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 115 generic and 25 proprietary products in the U.S. and more than 1,200 products globally outside of the U.S.

Forward-Looking Statements

Except for the historical information contained herein, the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements can be identified by their use of words such as "expects," "plans," "projects," "will," "may," "anticipates," "believes," "should," "intends," "estimates" and other words of similar meaning. Because such statements inherently involve risks and uncertainties that cannot be predicted or quantified, actual results may differ materially from those expressed or implied by such forward-looking statements depending upon a number of factors affecting the Company's business. These factors include, among others: the difficulty in predicting the timing and outcome of legal proceedings, including patent-related matters such as patent challenge settlements and patent infringement cases; the outcome of litigation arising from challenging the validity or non- infringement of patents covering our products; the difficulty of predicting the timing of FDA approvals; court and FDA decisions on exclusivity periods; the ability of competitors to extend exclusivity periods for their products; our ability to complete product development activities in the timeframes and for the costs we expect; market and customer acceptance and demand for our pharmaceutical products; our dependence on revenues from significant customers; reimbursement policies of third party payors; our dependence on revenues
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. SARS research confirms link to animals
2. Irritable bowel syndrome associated with food intake, confirms blood test
3. Skin tests confirms cancer
4. Roche confirms Tamiflu production talks in US
5. Local Test Confirms Bird Flu Related Death Of Indonesian Man
6. Surat in Gujarat,Confirms Bird flu Among Chickens
7. WHO Confirms Another Bird Flu Victim In Indonesia
8. Good news: there is no threat of bird flu confirms US
9. Orissa Confirms Bird’s Death In A Poultry Far
10. Interim WHO Chief Confirms No radical changes in WHO
11. China Confirms 19th Case Of Human Case Of Bird Flu
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Antares Achieves ISO Certification 2Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 2Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 3Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 4Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 5Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 6Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 7Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 8Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 9Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 10Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 11Health News:Reportlinker Adds Japanese Market for Women's Health Devices 2009 12Health News:Turning metal black more than just a novelty 2Health News:Too-Strict Blood Sugar Control May Lead to Car Crashes 2Health News:Too-Strict Blood Sugar Control May Lead to Car Crashes 3Health News:AUL Action Challenges Planned Parenthood to Reveal Financial Interest in Health Care Legislation 2
Breaking Medicine Technology:Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 2Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 3Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 4Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 5Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 6Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 7Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 8Reportlinker Adds Respiratory Care Equipment & Supplies - A Worldwide Market Review 9ThromboGenics NV Q3 2009 Business Update 14715 1ThromboGenics NV Q3 2009 Business Update 14715 2ThromboGenics NV Q3 2009 Business Update 14715 3ThromboGenics NV Q3 2009 Business Update 14715 4ThromboGenics NV Q3 2009 Business Update 14715 5ThromboGenics NV Q3 2009 Business Update 14715 6ThromboGenics NV Q3 2009 Business Update 14715 7Development of Batch and Continuous Chemical Processes Using Real Time In Situ FTIR Analytics as a Process Analytical Technology 28PAT 29 Tool 14712 1Development of Batch and Continuous Chemical Processes Using Real Time In Situ FTIR Analytics as a Process Analytical Technology 28PAT 29 Tool 14712 2American Competitive Trail Horse Association Announces Total Health Enhancement Corp as a Sponsor Member 60661 1American Competitive Trail Horse Association Announces Total Health Enhancement Corp as a Sponsor Member 60661 2